Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

2017 Agenda: Learn from expert pharma speakers and patients themselves with our panel discussions, roundtables and Individual presentations, to maximize your two days

Day One


7.30 - 8.50
Registration and Coffee - Networking & Exhibition
KEYNOTE SESSION - Culture eats strategy
8.50 - 9.00
Chair Opening Remarks

Teva Ruth Wilson Global Head of Patient Advocacy Teva

9.00 - 9.45
KEYNOTE LEADERSHIP PANEL
Aim for the stars! Create the patient-first business model by orienting your workforce around what value matters for society
  • Raise the bar: become a corporate citizen and identify how to deliver value health to society first, followed by individual patients
  • How to create a uniting force – see what leadership traits are required from middle management to realign the patient focus

Moderator: eyeforpharma Paul Simms Chair eyeforpharma

Panellists: Teva Jason DeGoes Senior Vice President Global Patient Solutions Teva

AstraZeneca Guy Yeoman Vice President, Patient Centricity AstraZeneca

Gilead Sciences Alex Kalomparis Vice President, Public Affairs - EMEA Gilead

Grünenthal Innovation Unit Pain Lars Joensson Vice President and Head of Patient Engagement Grünenthal Innovation Unit Pain

9.45 - 10.10
The journey to the beginning: How AstraZeneca defined patient centricity and the impact on the organisation
  • Learn how AZ has established some basic principles for a patient centric transformation program as it begins to refocus on how to engage patients.
  • Listen to how is AZ creating that momentum for change to build sustainable practices for the future
  • How is AZ demonstrating impact for patients

AstraZeneca Guy Yeoman Vice President, Patient Centricity AstraZeneca

10.10 - 10.35
How Ipsen is engaging employees to work and involve patients at every stage of the value chain
  • At Ipsen our employees are our biggest opportunity
  • Determine whether culture change should be top-down or bottom-up
  • Supporting colleagues to take pro-active steps to engage with patients in all cross-functional areas

Ipsen Isabelle Bocher-Pianka Chief Patient Affairs Officer Ipsen

10.35 - 11.00
Coffee Break - Networking & Exhibition
11.00 - 11.25
Our customer is the patient:” how is UCB’s patient-focussed model delivering value?
  • A close examination of whether UCB’s efforts to transform its DNA is creating commercial, cultural and collaborative capital
  • Appreciate the impact patient engagement is having on the company’s commercial goals

UCB Analia de la Fuente Global Head of Patient Ecosystem Insights Practice UCB

11.25 - 11.55
Can AI support authentic patient engagement: separating the hype from the hope
  • Hear insights from an ongoing INC/inVentiv Health research program looking at patient understanding and expectations of AI for healthcare
  • Understand the short and medium-term opportunities for meeting these needs successfully
  • Understand the nature of the current debate on AI’s role in healthcare, and the roles you need to play in its future

inVentiv Health Duncan Arbour EU Innovation Lead INC Research/inVentiv Health

11.55 - 12.20
Case Study Shire
Never give up! Learn how Shire overcame challenges on the implementation of a Patient Support Programme
  • Create defined objectives, co-ordinate organised exit strategies, centralise patient relationships
  • How to select and work with fewer, quality partners who generate real value – and even overcome compliance issues
  • How to use data to support decision making, clear obstacles and make your patient-focussed decisions more reliable

Shire Thomas Kerscher Global Head Patient & Customer Excellence Shire

12.20 - 12.50
Gaining Patient Insights to Support your Patient Initiatives: Methods and Benefits
  • Why patient insights are needed to support the development of any patient initiative
  • Innovative methodologies that provide an in-depth understanding of the patient perspective
  • The benefits of applying patient insights

Mapi Group Kelly Franchetti RN,CCRN,CEN Vice President, Global Patient Insights and Engagement Mapi Group

12.50 - 14.00
Lunch
A dose of digital - Value and Support in the Digital Era
14.00 - 14.25
Use digital technology to put the solution in your patient’s hands: how pharma can be disruptive and provide innovation around experiences
  • Embrace a different mindset to transform patient self-care empowerment into a holistic experience
  • Explore how digital solutions can fit into the changing landscape
  • Learn from pilots how value-adding digital services can optimise chronic patient care interventions

Sanofi Jan Liska Global Head of Patient Business Strategy Sanofi

14.25 - 14.55
Delivering Personalized Patient Support Programs: efficiently integrating digital support into the patient journey to address patient needs
  • Importance of Service Design in addressing patient and brand needs
  • Using digital to deliver therapy specific behavior change models to ensure support is specific to each patients’ circumstance
  • Moving from an episodic to a continuous patient support model

S3 Connected Health Matt Norton Director of Sales and Marketing S3 Connected Health

Workshops for Pharmaceutical Companies and Patients
14.55 - 15.50
ACCENTURE WORKSHOP
Are you “experienced”? Create a game-changing patient experience through Design Thinking

In a recent survey of over 200 Life Sciences executives, 78% believe that personalising the patient experience will be the new competitive differentiator.

In this workshop, we will aim to:

  • Demystify Design Thinking in healthcare:  explore the principles, pitfalls and cultural ramifications
  • Apply theory to practice: try your hand at using Design Thinking to create an effective patient experience for chronic and acute conditions

We will also share our perspectives on the role of Open Innovation in supporting this ambition

Accenture Fabio Sergio Managing Director Design Strategy Accenture

MICROMASS COMMUNICATIONS - AN ASHFIELD COMPANY - WORKSHOP
Applying Behavioral Science: The Key to Improving Patient Outcomes and Brand Performance
  • Traditional pharma marketing approaches that only provide education and information are not enough to change patient behavior
  • Evidence-based strategies from behavioral science and health psychology provide a roadmap to change patient behavior
  • In this workshop, you will gain an understanding of the factors that impact behavior, evaluate traditional patient support tactics, and identify ways behavioral science strategies can be incorporated to achieve better outcomes

MicroMass Communications, Inc., an Ashfield company Jessica Brueggeman, RN, MPH EVP, Health Behavior Group MicroMass Communications - an Ashfield company

15.50 - 16.15
Coffee Break - Networking & Exhibition
‘Most Valuable Patient Initiative’ eyeforpharma awards winners and finalists
16.15 - 16.40
EYEFORPHARMA AWARD WINNER
Explore Empathy: How Takeda’s #FlywithIBD and #InTheirShoes programmes deepened patient understanding and inspired collaboration with staff and HCPs
  • Understand the oft-overlooked role of your internal communications team in supporting patient outcomes
  • Do experiential programmes always work? An examination of results to date, lessons learned and future directions

Takeda Audrey Liechti Senior Communications Manager Takeda

16.40 - 17.05
EYEFORPHARMA AWARD WINNER
AbbVie’s YouTube Doctor’s Channel – giving physicians a voice
  • See how AbbVie became the trusted partner by simplifying complex medical information and making it accessible to patients by using physicians as online coaches.
  • Where quality shines through: how and why the channel quickly became popular and respected, and the measured impact on patients
  • Understand what internal and external support was required to make the product work

AbbVie Fiona Olivier Director of Public Affairs, Western Europe & Canada AbbVie

AbbVie Doron Obazanek Public Affairs Manager AbbVie

17.05 - 17.30
EYEFORPHARMA AWARD FINALIST
Fight Idiopathic pulmonary fibrosis (IPF) with Roche!
  • From idea to implementation: how Roche built the innovative FightIPF campaign across Europe and Canada to raise awareness of an aggressive, unpredictable disease.
  • A look at how Roche was inspired by the Philips Breathless Choir to develop an integrated campaign, with a hero video sitting at the very core.
  • How compliance and internal support issues were fought for the good of the patient

Roche Peter Verwaijen International Product Manager Roche

17.30 -17.45
Chair Conclusions
17.45 -19.15
Networking Drinks - The end of the Day 1

Day Two


7.30 - 8.45
Registration and Coffee - Networking & Exhibition
The Virtuous Circle - Real Insight for Real Impact
8.45 - 9.00
Chair Opening Remarks

Robert Gallo Communications & Patient Engagement Advisor  

9.00 - 9.45
PATIENT PANEL
We believe, but do patients see us as their partner of choice? The roadmap to gaining trust and rebuilding pharma’s reputation
  • Assess the most recent results of the PatientView Global Corporate
  • Reputation Report - why is pharma not meeting society’s expectations?
  • Why the partnership, support and even creation of long-term associations makes sense within your business model
  • How patient associations can trigger the fundamental reorientation of employee attitudes towards your company’s success

Moderator: Teva Ruth Wilson Global Head of Patient Advocacy Teva

Panellists: Patient View Alexandra Wyke CEO Patient View

the World Alliance of Pituitary Organizations (WAPO) Sheila Khawaja Vice-Chair the World Alliance of Pituitary Organizations (WAPO)

Epilepsy Society UK Jasmine Smith Member of Trustee Board Epilepsy Society UK

European Young Person’s Advisory Group Network (eYPAGnet) Simon Stones Patient Advocate and NIHR Young Patient Research Ambassador representing the European Young Person’s Advisory Group Network (eYPAGnet)

9.45 - 10.15
Define the best profile of a therapy - Focus on the pathway, not the drug.
  • Establish partnerships with patients which add value to the drug development based on unmet medical needs.
  • How to “translate” patient expectations and unmet needs to pathways and targets
  • How to define profile of an “ideal” therapy together with patients
  • Determine when and where patient-industry collaborations make sense.

ViiV Healthcare Dr Oleksandr Gorbenko Global Patient Affairs Medical Lead ViiV Healthcare

European AIDS Treatment Group Damian Kelly Chair Training and Capacity Building European AIDS Treatment Group

10.15 - 11.00
CO-CREATION MASTERCLASS
Listen, learn, implement, repeat - Effective ways to partner with patients
  • Co-creating and providing materials that patients want and need
  • Understand how to demonstrate your commitment to co-creation to patients

Moderator: Oxford PharmaGenesis Richard White Director Oxford PharmaGenesis

Panellists: PIF - Patient Information Forum Claire Murray Joint Head of Operations PIF - Patient Information Forum

NCRI - National Cancer Research Institute Richard Stephens Consumer Lead and Chair of Consumer Forum NCRI - National Cancer Research Institute

Pfizer David Montgomery Vice President, Science Exchange, Oncology Pfizer

11.00 - 11.30
Coffee Break - Networking & Exhibition
11.30 - 11.55
One size does NOT fit all: how to create personalised and engaging patient support programs
  • With the use of a combined behavioural psychology and a storytelling approach, examine why beliefs and motivations matter
  • Understand the role that pharma can play in helping patients to develop new skills and change behaviour
  • Learn how behavioural change can increase patient adherence and self-management

Teva Carla van de Guchte Director European Operations, Patient Solutions Teva

11.55 - 13.00
ROUNDTABLES - Time to get your sleeves rolled up

Topics we will be covering. The best way of learning is doing!

1 A. Maintaining long-term relationships with patients - Led by experts from Patientys

1 B. Maintaining long-term relationships with patients - Led by Natacha Bolaños, EUPATI

2 A. Early engagement: bringing patients into drug planning and trial design - Led by experts from KPMG

2 B. Early engagement: bringing patients into drug planning and trial design - Led by Fiona Oliver & Doron Obazanek, Abbvie

3 A. Value and access: How advocacy of the future will evolve - Led by experts from Envision Pharma Group

3 B. Value and access: How advocacy of the future will evolve - Led by Audrey Liechti, Takeda

4 A. New era interaction: digital platforms for real engagement - Led by experts from FindMeCure

4 B. New era interaction: digital platforms for real engagement - Led by Karen Cheng, Independent Patient

5. Medical Education and the empowered patient: make it accessible – Led by experts from Bedrock Healthcare Communications

6. Culture club: How we can change behaviour across the company - Led by Trishna Bharadia, Independent Patient

7. Beyond the patient: are we fully harnessing the power of the ‘non-patient’? - Led by experts from Hive Health

13.00 - 14.00
LUNCH
14.00 - 14.25
EYEFORPHARMA AWARD FINALIST
Risk-share with a patient support programme - how UCB changed the rules with its Health Ecosystem Solution Project
  • Understand the essential foundations of a focus on solutions beyond the pill which impact patient lives and create extensive stakeholder value.
  • Learn how the project moved the narrative within UCB from merely treating patients to taking care of people, designing and implementing patient solutions that truly impact lives.
  • The requirements for a risk-sharing agreement with a patient support programme

UCB Cristina Ferragut Project Leader of Health Ecosystem Solution UCB

14.25 - 15.10
ENGAGEMENT PANEL
Make engagement happen - Overcome the barriers to patient engagement and involvement
  • Key barriers and limitations within PE area
  • Smart ways to measure engagement and communicate progress internally in bigger organizations
  • Trust in technology: move beyond buzzwords and see what really works
  • How to overcome the legal hurdles

MODERATOR: ViiV Healthcare Dr. Oleksandr Gorbenko Global Patient Affairs Medical Lead ViiV Healthcare

PANELISTS: PFMD Nicholas Brooke Chief Executive PFMD

EUPATI Natacha Bolaños Patient Expert EUPATI

15.10 - 15.35
Hear the patient’s voice - how patient centricity at AstraZeneca has accelerated through the use of personalised health networks
  • Listen to how the collaboration between AstraZeneca and PatientsLikeMe has helped teams rapidly identify outcomes that matter to patients
  • Understand what impacts patient experience of research and how to make it easier for patients to join and stay in clinical studies

AstraZeneca Cathy Emmas Patient Centricity Partnership Director AstraZeneca

15.35 - 15.45
Chair Conclusions
15.45 - 16.15
Coffee - The end of the congress

Day One


7.30 - 8.50
Registration and Coffee - Networking & Exhibition
KEYNOTE SESSION - Culture eats strategy
8.50 - 9.00
Chair Opening Remarks

Teva Ruth Wilson Global Head of Patient Advocacy Teva

9.00 - 9.45
KEYNOTE LEADERSHIP PANEL
Aim for the stars! Create the patient-first business model by orienting your workforce around what value matters for society
  • Raise the bar: become a corporate citizen and identify how to deliver value health to society first, followed by individual patients
  • How to create a uniting force – see what leadership traits are required from middle management to realign the patient focus

Moderator: eyeforpharma Paul Simms Chair eyeforpharma

Panellists: Teva Jason DeGoes Senior Vice President Global Patient Solutions Teva

AstraZeneca Guy Yeoman Vice President, Patient Centricity AstraZeneca

Gilead Sciences Alex Kalomparis Vice President, Public Affairs - EMEA Gilead

Grünenthal Innovation Unit Pain Lars Joensson Vice President and Head of Patient Engagement Grünenthal Innovation Unit Pain

9.45 - 10.10
The journey to the beginning: How AstraZeneca defined patient centricity and the impact on the organisation
  • Learn how AZ has established some basic principles for a patient centric transformation program as it begins to refocus on how to engage patients.
  • Listen to how is AZ creating that momentum for change to build sustainable practices for the future
  • How is AZ demonstrating impact for patients

AstraZeneca Guy Yeoman Vice President, Patient Centricity AstraZeneca

10.10 - 10.35
How Ipsen is engaging employees to work and involve patients at every stage of the value chain
  • At Ipsen our employees are our biggest opportunity
  • Determine whether culture change should be top-down or bottom-up
  • Supporting colleagues to take pro-active steps to engage with patients in all cross-functional areas

Ipsen Isabelle Bocher-Pianka Chief Patient Affairs Officer Ipsen

10.35 - 11.00
Coffee Break - Networking & Exhibition
11.00 - 11.25
Our customer is the patient:” how is UCB’s patient-focussed model delivering value?
  • A close examination of whether UCB’s efforts to transform its DNA is creating commercial, cultural and collaborative capital
  • Appreciate the impact patient engagement is having on the company’s commercial goals

UCB Analia de la Fuente Global Head of Patient Ecosystem Insights Practice UCB

11.25 - 11.55
Can AI support authentic patient engagement: separating the hype from the hope
  • Hear insights from an ongoing INC/inVentiv Health research program looking at patient understanding and expectations of AI for healthcare
  • Understand the short and medium-term opportunities for meeting these needs successfully
  • Understand the nature of the current debate on AI’s role in healthcare, and the roles you need to play in its future

inVentiv Health Duncan Arbour EU Innovation Lead INC Research/inVentiv Health

11.55 - 12.20
Case Study Shire
Never give up! Learn how Shire overcame challenges on the implementation of a Patient Support Programme
  • Create defined objectives, co-ordinate organised exit strategies, centralise patient relationships
  • How to select and work with fewer, quality partners who generate real value – and even overcome compliance issues
  • How to use data to support decision making, clear obstacles and make your patient-focussed decisions more reliable

Shire Thomas Kerscher Global Head Patient & Customer Excellence Shire

12.20 - 12.50
Gaining Patient Insights to Support your Patient Initiatives: Methods and Benefits
  • Why patient insights are needed to support the development of any patient initiative
  • Innovative methodologies that provide an in-depth understanding of the patient perspective
  • The benefits of applying patient insights

Mapi Group Kelly Franchetti RN,CCRN,CEN Vice President, Global Patient Insights and Engagement Mapi Group

12.50 - 14.00
Lunch
A dose of digital - Value and Support in the Digital Era
14.00 - 14.25
Use digital technology to put the solution in your patient’s hands: how pharma can be disruptive and provide innovation around experiences
  • Embrace a different mindset to transform patient self-care empowerment into a holistic experience
  • Explore how digital solutions can fit into the changing landscape
  • Learn from pilots how value-adding digital services can optimise chronic patient care interventions

Sanofi Jan Liska Global Head of Patient Business Strategy Sanofi

14.25 - 14.55
Delivering Personalized Patient Support Programs: efficiently integrating digital support into the patient journey to address patient needs
  • Importance of Service Design in addressing patient and brand needs
  • Using digital to deliver therapy specific behavior change models to ensure support is specific to each patients’ circumstance
  • Moving from an episodic to a continuous patient support model

S3 Connected Health Matt Norton Director of Sales and Marketing S3 Connected Health

Workshops for Pharmaceutical Companies and Patients
14.55 - 15.50
ACCENTURE WORKSHOP
Are you “experienced”? Create a game-changing patient experience through Design Thinking

In a recent survey of over 200 Life Sciences executives, 78% believe that personalising the patient experience will be the new competitive differentiator.

In this workshop, we will aim to:

  • Demystify Design Thinking in healthcare:  explore the principles, pitfalls and cultural ramifications
  • Apply theory to practice: try your hand at using Design Thinking to create an effective patient experience for chronic and acute conditions

We will also share our perspectives on the role of Open Innovation in supporting this ambition

Accenture Fabio Sergio Managing Director Design Strategy Accenture

MICROMASS COMMUNICATIONS - AN ASHFIELD COMPANY - WORKSHOP
Applying Behavioral Science: The Key to Improving Patient Outcomes and Brand Performance
  • Traditional pharma marketing approaches that only provide education and information are not enough to change patient behavior
  • Evidence-based strategies from behavioral science and health psychology provide a roadmap to change patient behavior
  • In this workshop, you will gain an understanding of the factors that impact behavior, evaluate traditional patient support tactics, and identify ways behavioral science strategies can be incorporated to achieve better outcomes

MicroMass Communications, Inc., an Ashfield company Jessica Brueggeman, RN, MPH EVP, Health Behavior Group MicroMass Communications - an Ashfield company

15.50 - 16.15
Coffee Break - Networking & Exhibition
‘Most Valuable Patient Initiative’ eyeforpharma awards winners and finalists
16.15 - 16.40
EYEFORPHARMA AWARD WINNER
Explore Empathy: How Takeda’s #FlywithIBD and #InTheirShoes programmes deepened patient understanding and inspired collaboration with staff and HCPs
  • Understand the oft-overlooked role of your internal communications team in supporting patient outcomes
  • Do experiential programmes always work? An examination of results to date, lessons learned and future directions

Takeda Audrey Liechti Senior Communications Manager Takeda

16.40 - 17.05
EYEFORPHARMA AWARD WINNER
AbbVie’s YouTube Doctor’s Channel – giving physicians a voice
  • See how AbbVie became the trusted partner by simplifying complex medical information and making it accessible to patients by using physicians as online coaches.
  • Where quality shines through: how and why the channel quickly became popular and respected, and the measured impact on patients
  • Understand what internal and external support was required to make the product work

AbbVie Fiona Olivier Director of Public Affairs, Western Europe & Canada AbbVie

AbbVie Doron Obazanek Public Affairs Manager AbbVie

17.05 - 17.30
EYEFORPHARMA AWARD FINALIST
Fight Idiopathic pulmonary fibrosis (IPF) with Roche!
  • From idea to implementation: how Roche built the innovative FightIPF campaign across Europe and Canada to raise awareness of an aggressive, unpredictable disease.
  • A look at how Roche was inspired by the Philips Breathless Choir to develop an integrated campaign, with a hero video sitting at the very core.
  • How compliance and internal support issues were fought for the good of the patient

Roche Peter Verwaijen International Product Manager Roche

17.30 -17.45
Chair Conclusions
17.45 -19.15
Networking Drinks - The end of the Day 1

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Day Two


7.30 - 8.45
Registration and Coffee - Networking & Exhibition
The Virtuous Circle - Real Insight for Real Impact
8.45 - 9.00
Chair Opening Remarks

Robert Gallo Communications & Patient Engagement Advisor  

9.00 - 9.45
PATIENT PANEL
We believe, but do patients see us as their partner of choice? The roadmap to gaining trust and rebuilding pharma’s reputation
  • Assess the most recent results of the PatientView Global Corporate
  • Reputation Report - why is pharma not meeting society’s expectations?
  • Why the partnership, support and even creation of long-term associations makes sense within your business model
  • How patient associations can trigger the fundamental reorientation of employee attitudes towards your company’s success

Moderator: Teva Ruth Wilson Global Head of Patient Advocacy Teva

Panellists: Patient View Alexandra Wyke CEO Patient View

the World Alliance of Pituitary Organizations (WAPO) Sheila Khawaja Vice-Chair the World Alliance of Pituitary Organizations (WAPO)

Epilepsy Society UK Jasmine Smith Member of Trustee Board Epilepsy Society UK

European Young Person’s Advisory Group Network (eYPAGnet) Simon Stones Patient Advocate and NIHR Young Patient Research Ambassador representing the European Young Person’s Advisory Group Network (eYPAGnet)

9.45 - 10.15
Define the best profile of a therapy - Focus on the pathway, not the drug.
  • Establish partnerships with patients which add value to the drug development based on unmet medical needs.
  • How to “translate” patient expectations and unmet needs to pathways and targets
  • How to define profile of an “ideal” therapy together with patients
  • Determine when and where patient-industry collaborations make sense.

ViiV Healthcare Dr Oleksandr Gorbenko Global Patient Affairs Medical Lead ViiV Healthcare

European AIDS Treatment Group Damian Kelly Chair Training and Capacity Building European AIDS Treatment Group

10.15 - 11.00
CO-CREATION MASTERCLASS
Listen, learn, implement, repeat - Effective ways to partner with patients
  • Co-creating and providing materials that patients want and need
  • Understand how to demonstrate your commitment to co-creation to patients

Moderator: Oxford PharmaGenesis Richard White Director Oxford PharmaGenesis

Panellists: PIF - Patient Information Forum Claire Murray Joint Head of Operations PIF - Patient Information Forum

NCRI - National Cancer Research Institute Richard Stephens Consumer Lead and Chair of Consumer Forum NCRI - National Cancer Research Institute

Pfizer David Montgomery Vice President, Science Exchange, Oncology Pfizer

11.00 - 11.30
Coffee Break - Networking & Exhibition
11.30 - 11.55
One size does NOT fit all: how to create personalised and engaging patient support programs
  • With the use of a combined behavioural psychology and a storytelling approach, examine why beliefs and motivations matter
  • Understand the role that pharma can play in helping patients to develop new skills and change behaviour
  • Learn how behavioural change can increase patient adherence and self-management

Teva Carla van de Guchte Director European Operations, Patient Solutions Teva

11.55 - 13.00
ROUNDTABLES - Time to get your sleeves rolled up

Topics we will be covering. The best way of learning is doing!

1 A. Maintaining long-term relationships with patients - Led by experts from Patientys

1 B. Maintaining long-term relationships with patients - Led by Natacha Bolaños, EUPATI

2 A. Early engagement: bringing patients into drug planning and trial design - Led by experts from KPMG

2 B. Early engagement: bringing patients into drug planning and trial design - Led by Fiona Oliver & Doron Obazanek, Abbvie

3 A. Value and access: How advocacy of the future will evolve - Led by experts from Envision Pharma Group

3 B. Value and access: How advocacy of the future will evolve - Led by Audrey Liechti, Takeda

4 A. New era interaction: digital platforms for real engagement - Led by experts from FindMeCure

4 B. New era interaction: digital platforms for real engagement - Led by Karen Cheng, Independent Patient

5. Medical Education and the empowered patient: make it accessible – Led by experts from Bedrock Healthcare Communications

6. Culture club: How we can change behaviour across the company - Led by Trishna Bharadia, Independent Patient

7. Beyond the patient: are we fully harnessing the power of the ‘non-patient’? - Led by experts from Hive Health

13.00 - 14.00
LUNCH
14.00 - 14.25
EYEFORPHARMA AWARD FINALIST
Risk-share with a patient support programme - how UCB changed the rules with its Health Ecosystem Solution Project
  • Understand the essential foundations of a focus on solutions beyond the pill which impact patient lives and create extensive stakeholder value.
  • Learn how the project moved the narrative within UCB from merely treating patients to taking care of people, designing and implementing patient solutions that truly impact lives.
  • The requirements for a risk-sharing agreement with a patient support programme

UCB Cristina Ferragut Project Leader of Health Ecosystem Solution UCB

14.25 - 15.10
ENGAGEMENT PANEL
Make engagement happen - Overcome the barriers to patient engagement and involvement
  • Key barriers and limitations within PE area
  • Smart ways to measure engagement and communicate progress internally in bigger organizations
  • Trust in technology: move beyond buzzwords and see what really works
  • How to overcome the legal hurdles

MODERATOR: ViiV Healthcare Dr. Oleksandr Gorbenko Global Patient Affairs Medical Lead ViiV Healthcare

PANELISTS: PFMD Nicholas Brooke Chief Executive PFMD

EUPATI Natacha Bolaños Patient Expert EUPATI

15.10 - 15.35
Hear the patient’s voice - how patient centricity at AstraZeneca has accelerated through the use of personalised health networks
  • Listen to how the collaboration between AstraZeneca and PatientsLikeMe has helped teams rapidly identify outcomes that matter to patients
  • Understand what impacts patient experience of research and how to make it easier for patients to join and stay in clinical studies

AstraZeneca Cathy Emmas Patient Centricity Partnership Director AstraZeneca

15.35 - 15.45
Chair Conclusions
15.45 - 16.15
Coffee - The end of the congress

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription